Week 2- Part 5- Mechanisms of drug action (after NT release). Flashcards

1
Q

What do they target?

A

Processes that normally happen after NTs are released into the synapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Effects on receptors:

What is the most important and most complex site of action for psychoactive drugs?

What can some drugs do?

What are the two additional categories?

A

On both the presynaptic and postsynaptic receptors.

Bind to receptors and act as either agonists or antagonists.

Inverse agonists and neuromodulators.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a direct agonist?

What does it increase?

A

Drug which slots into the same receptor as the NT would- has the same effect- mimicking the NT.

Activity within that NT system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a direct antagonist?

What is this useful in?

A

Drug goes into the receptor used by the NT- blocks or reverses the effects of the NT- e.g. pushing it out.

Treating overdoses- reverses the effects of drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is an inverse agonist?

What is a neuromodulator?

A

Drug combines to receptor site as the NT would- has the opposite effect to NT.

Have a drug which does not bind directly to where the NT would bind but somewhere else on the receptor complex- modifies the effect of NT- makes the NT effects stronger or weaker- can increase or inhibit effects of a neurotransmitter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the sixth one?

What can a drug do?

Give an example of what some drugs do.

What happens at neuromuscular junctions?

A

Drugs stimulating postsynaptic receptors.

Bind to postsynaptic receptors + mimic the effects of the NT- i.e., act as an agonist.

Mimic effects of acetylcholine (major NT in the ANS + neuromuscular junctions + CNS).

Nerves connect to your skeletal muscles and activate them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Continuation from the sixth one:

What is there?

What is the first?

What would they be considered?

What happens with it?

A

Two major types of acetylcholine receptor.

Nicotinic ACh receptors.

Ionotropic.

Ion channel gets opened when acetylcholine binds- normally a sodium channel- sodium ions rush in- are excitatory- due to influx of positively charged sodium ion- cause an excitatory postsynaptic potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Continuation from the sixth one- Nicotinic ACh receptors:

What binds together?

How do they respond?

A

Nicotine in cigarettes- binds to- nicotinic acetylcholine receptors- mimics acetylcholine- opens the channels.

Fast.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Continuation from the sixth one:

What is the second type?

What would they be considered?

What are they varied in?

What is a crucial thing to remember?

Where does muscarinic come from?

A

Muscarinic ACh receptor.

Metabotropic.

What they do.

It is not directly associated with an ion channel- are associated with metabotropic second messenger system- open other ion channels and trigger all sorts of cellular effects.

Mushrooms- binds to muscarinic acetylcholine receptors- mimic the effects of acetylcholine there.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What kind of muscle is the nicotinic in?

What kind of muscle is the muscarinic in?

What is there for the previous?

Are they fast or slow?

A

Skeletal muscle (neuromuscular joints), ganglia and CNS.

CNS + smooth muscle of the ANS (controls things like blood vessel dilation, cardiac muscle etc).

Different types- some can be excitatory + some inhibitory.

Slower.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neuromodulator:

What is GABA?

What would it be considered?

Give examples.

What does the previous do?

A

Major inhibitory NT in the CNS.

Ionotropic receptor- normally opens chloride ion channels- leads to hyperpolarization- makes neurons less likely to fire.

Sedatives + anxiolytics such as benzodiazepines.

Bind to a different part of the complex- facilitate action of GABA- do not mimic it- make it more potent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is seventh?

What might a drug bind to?

Give two examples.

A

Drugs can act as antagonists and block postsynaptic receptors.

Postsynaptic receptors and block effects of NTs- i.e., act as an antagonist.

Atropine + Curare.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Continuation from the seventh:

What is atropine?

What does it do?

Where are many of the metabotropic receptors?

What does a high dose do?

A

ACh antagonist.

Binds and blocks muscarinic receptors- blocks its effects.

In the brain.

Disrupt memory.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Continuation from the seventh:

What is curare?

What does it do?

What does it cause?

A

ACh antagonist- it is naturally occurring + derived from plants.

Bind and block nicotinic receptors, the ionotropic receptors at the neuromuscular junction.

Paralysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is eigth?

Explain it.

A

Drugs bind to autoreceptor- may mimic effects of NTs at its presynaptic autoreceptors.

Presynaptic cell releases synapses- diffuse across synapse- acts as a postsynaptic receptors on its membrane- some NTs act as autoreceptors that exist on the presynaptic cell- form negative feedback mechanism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Continuation from the eighth:

What are they there for?

Essentially, when NTs bind to presynaptic autoreceptors, what are they doing?

A

To detect how much NT is in the synapse.

Telling the presynaptic neuron that it has released enough of it so stop- job is to run down the release of more of the same NT molecule- this is part of a negative feedback regulatory system.

17
Q

Continuation from the eighth:

What does it essentially do?

Why does this create a problem for clinicians when trying to develop treatments for psychological disorders?

A

Trick the presynaptic cell into thinking too much NT has been released- This will inhibit the release of more (negative feedback mechanism).

E.g. have a drug treatment- aims to increase availability of a particular NT- if these go back and activate autoreceptors, will stimulate the negative feedback mechanism + reduce what needs to be released- will limit the effect of certain drugs.

18
Q

What is the ninth?

What will this prevent?

A

Drugs can block autoreceptors- Block the effect of NT at the presynaptic autoreceptors.

Negative feedback system working.

19
Q

Continuation from the ninth:

What else will it prevent?

What can it lead to?

A

NT- telling the presynaptic cell that you have released enough of me- the presynaptic cell will keep releasing more.

Increased availability of NT at the synapse.

20
Q

Drugs stimulate postsynaptic receptors and autoreceptors:

What makes a complicated situation?

What does a low dose do?

What does a high dose do?

A

If drug (with a similar molecular structure) mimics NT at both postsynaptic receptors and autoreceptors.

Might activate autoreceptors and reduce availability of NT.

Might lead to increased levels of postsynaptic receptor activation- might activate the postsynaptic receptors directly and produce lots of effects.

21
Q

What is another way NT can be removed by the synapse?

A

Uptake by the glial cell.

22
Q

What is the tenth?

Where?

What does this do?

A

Drugs blocks NT molecules reuptake- block the functioning of these pumps.

In the presynaptic neuron.

Increases the availability of NT in the synapse- short term.

23
Q

Continuation from the tenth:

Give an example.

Give another example.

A

E.g. tricyclic antidepressants (TCAs) block reuptake of serotonin and noradrenaline- increased availability of these NTs at the synapse.

SSRIs- preferentially block reuptake of serotonin- increase serotonin at synapses- they are a subtype of tricyclic antidepressants.

24
Q

What is the eleventh?

What can a drug do?

What does this do?

Give an example.

What are they used to treat?

A

Effects on NT degradation.

Inactivate (inhibit) the enzyme that normally breaks down the NT in the synapse.

Increases the availability of NT in the synapse (so increases effects on postsynaptic receptors).

E.g. MAOIs prevent breakdown of monoamines- block the enzyme MAO.

MAOIs are used to treat depression and Parkinson’s disease.

25
Q

Continuation from the eleventh:

What are other examples?

What do they do?

What do they prevent?

What happens to acetylcholine?

A

Novichoks (and some other nerve agents).

Inhibit the enzyme which breaks down acetylcholine- are acetylcholinesterase inhibitors.

Prevent the normal breakdown of acetylcholine after release.

Acetylcholine builds up at neuromuscular junctions causing involuntary muscle contractions.

26
Q

Continuation from the eleventh:

What do they have a similar effect to?

What does this class of drug have?

A

Have an effect similar to black widow spider venom- instead of increasing acetylcholine release, they block acetylcholine breakdown.

Clinical usage- in low doses- example- used to treat dementia- because some symptoms are due to deficits in acetylcholine activity- use acetylcholinesterase inhibitors- this increases the availability of acetylcholine.

27
Q

Continuation from the eleventh:

What else is it used to treat?

What is it?

What does it lead to?

A

Disorder called myasthenia gravis.

Autoimmune disorder- the immune system attacks nicotinic acetylcholine receptors- so not many available to work- creates problems initiating muscle contractions (stimulation).

Weakness and fatigue + drooping face muscles.

28
Q

Continuation from the eleventh- myasthenia gravis:

What does it make the body do?

What is it treated with and why?

A

Produce antibodies against ACh nicotinic receptors.

With acetylcholinesterase inhibitors- because they increase the availability of acetylcholine at neuromuscular junctions- then increase activity within the muscle.